ABI
CBST

Adamant Biomedical Investments’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Adamant Biomedical Investments’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.42M Hold
24,000
– – 0.58% 57
2014
Q3 		$1.59M Buy
+24,000
New +$1.58M 0.4% 69

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adamant Biomedical Investments's CBST Position: Q4 2014 in Review

Adamant Biomedical Investments held its CUBIST PHARMACEUTICALS INC (CBST) position steady in Q4 2014 at 24,000 shares worth $2.42M. The position accounts for 0.58% of the portfolio, ranked #57.

Adamant Biomedical Investments first reported a position in CBST in Q3 2014 and has held it in 2 quarters since. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Adamant Biomedical Investments held 24,000 shares of CUBIST PHARMACEUTICALS INC worth $2.42M as of Q4 2014.
  • Adamant Biomedical Investments left its CUBIST PHARMACEUTICALS INC share count unchanged in Q4 2014.
  • CUBIST PHARMACEUTICALS INC made up 0.58% of Adamant Biomedical Investments's portfolio in Q4 2014, its #57 holding.
  • Adamant Biomedical Investments first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2014 and has held it in 2 quarters since.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.